Upcoming Events
Notices
March 20, 2023
Patented (Symbiosis, Inc.)
We are pleased to announce that we have been granted a patent for “Bioinduction Aid Solvent and Method of Using the Same,” for which an application was filed by Symbiosis, Inc. Patent Information [Patent No.] Patent No. 7231799 [Title of the Invention] “Bioinduction Aid Solvent and Method of Using the Same” […
February 20, 2023
Patented (Symbiosis, Inc.)
We are pleased to announce that we have been granted a patent for “Composition Containing Biological Microorganisms and Method for Producing the Same,” for which an application was filed by Symbiosis, Inc. Patent Information [Patent No.] Patent No. 7104435 [Title of Invention] “Composition Containing Biological Microorganisms and Method for Making the Composition […
December 16, 2022
U.S. FDA approves first fecal microbiota product
On November 30, 2022, the U.S. Food and Drug Administration (FDA) approved FerringPharma’s fecal microbiota product, Rebyota, for the treatment of rCDI, the first time the FDA has approved a fecal microbiota product […
October 05, 2022
The 6th Annual Conference [Report]
The 6th Annual Scientific Meeting, held on Sunday, September 18, 2022, was held simultaneously at the venue and online. It was attended by many people, including medical professionals, general business people, people from research institutions, patients, and the general public. Despite the corona pandemic, everyone […]
July 11, 2022
Thank You for Achieving Crowdfunding Goal
The crowdfunding project “We want to provide children with autism spectrum disorder with treatment that opens up a bright future” that started on Saturday, May 14, 2022, ended at 23:59 on Sunday, July 10, 2010. Thanks to your support, we have reached our goal of […].
June 20, 2022
Patented (Symbiosis, Inc.)
We are pleased to announce that we have filed applications for “bubble shear filter, ultrafine bubble generator, and method for producing ultrafine bubble fluid” and “rotating mixer, ultrafine bubble generator, and ultrafine bubble […]” from Synbiosis, Inc.